Open AccessMetadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis
Author(s) -
Fátima Higuera-de la Tijera
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i16.4975
Subject(s) - medicine , abstinence , gastroenterology , alcoholic hepatitis , alcoholic liver disease , cirrhosis , psychiatry
To evaluate the impact of metadoxine (MTD) on the 3- and 6-mo survival of patients with severe alcoholic hepatitis (AH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom